Maia Biotechnology Stock Analysis

MAIA Stock Analysis Notes

About 21.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.49. MAIA Biotechnology had not issued any dividends in recent years. MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. The company was founded in 2018 and is headquartered in Chicago, Illinois. Maia Biotechnology operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 9 people. To find out more about MAIA Biotechnology contact the company at 312 416 8592 or learn more at https://www.MAIABiotech.com.

MAIA Biotechnology Investment Alerts

MAIA Biotechnology Upcoming and Recent Events

MAIA Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MAIA Biotechnology's market, we take the total number of its shares issued and multiply it by MAIA Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

MAIA Profitablity

Technical Drivers

As of the 23rd of April, MAIA Biotechnology secures the Downside Deviation of 4.83, mean deviation of 4.6, and Market Risk Adjusted Performance of 0.5295. Compared to fundamental indicators, the technical analysis model lets you check possible technical drivers of MAIA Biotechnology, as well as the relationship between them. Strictly speaking, you can use this information to find out if the entity will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for MAIA Biotechnology, which can be compared to its peers in the industry. Please verify MAIA Biotechnology standard deviation, treynor ratio, downside variance, as well as the relationship between the information ratio and value at risk to decide if MAIA Biotechnology is priced fairly, providing market reflects its recent price of 2.46 per share. Please also check out MAIA Biotechnology total risk alpha, which is currently at 0.2695 to check the company can sustain itself in the future.

MAIA Biotechnology Price Movement Analysis

MAIA Biotechnology Insider Trading Activities

MAIA Biotechnology Predictive Daily Indicators

MAIA Biotechnology Corporate Filings

MAIA Biotechnology Forecast Models

MAIA Biotechnology's time-series forecasting models are one of many MAIA Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MAIA Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how MAIA Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MAIA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MAIA Biotechnology. By using and applying MAIA Stock analysis, traders can create a robust methodology for identifying MAIA entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MAIA analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MAIA analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

MAIA Biotechnology stock analysis indicators help investors evaluate how MAIA Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MAIA Biotechnology shares will generate the highest return on investment. By understating and applying MAIA Biotechnology stock analysis, traders can identify MAIA Biotechnology position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MAIA Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.

Is MAIA Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MAIA Biotechnology. If investors know MAIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MAIA Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of MAIA Biotechnology is measured differently than its book value, which is the value of MAIA that is recorded on the company's balance sheet. Investors also form their own opinion of MAIA Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is MAIA Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MAIA Biotechnology's market value can be influenced by many factors that don't directly affect MAIA Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MAIA Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if MAIA Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MAIA Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.